XML 58 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUITY (Details 2) (USD $)
12 Months Ended
Dec. 31, 2013
item
Dec. 31, 2012
Dec. 31, 2011
Stock options
     
EQUITY      
Number of plans under award 3    
Expiration term 10 years    
Number of shares authorized for grant 1,500,000    
Number of shares available for future grant 879,000    
Shares      
Outstanding at the beginning of the period (in shares) 434,512    
Granted (in shares) 216,600    
Exercised (in shares) (256,336)    
Cancelled, expired or forfeited (in shares) (1,000)    
Outstanding at the end of the period (in shares) 393,776 434,512  
Exercisable at the end of the period (in shares) 145,138    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 18.93    
Granted (in dollars per share) $ 25.56    
Exercised (in dollars per share) $ 18.99    
Cancelled, expired or forfeited (in dollars per share) $ 25.25    
Outstanding at the end of the period (in dollars per share) $ 22.52 $ 18.93  
Exercisable at the end of the period (in dollars per share) $ 18.76    
Aggregate Intrinsic Value      
Outstanding at the end of the period (in dollars) $ 5,742,000    
Exercisable at the end of the period (in dollars) 2,661,000    
Weighted Average Remaining Contractual Term      
Outstanding at the end of the period 7 years 8 months 12 days    
Exercisable at the end of the period 5 years 4 months 24 days    
Additional disclosures      
Weighted average grant date fair value (in dollars per share) $ 5.06 $ 4.03 $ 4.04
Total intrinsic value of stock options exercised 2,400,000 497,000 39,000
Significant weighted-average assumptions relating to the valuation of each option grant      
Expected life 3 years 3 months 18 days 3 years 3 months 18 days 3 years 3 months 18 days
Expected volatility (as a percent) 36.00% 39.00% 46.00%
Risk-free interest rate (as a percent) 0.40% 0.40% 1.20%
Expected dividend yield (as a percent) 3.40% 4.10% 4.50%
Stock options | Minimum
     
EQUITY      
Award vesting period from the date of grant 1 year    
Stock options | Minimum | Non-employee directors
     
EQUITY      
Vesting requirement condition, percentage of attendance in regularly scheduled board meetings 75.00%    
Stock options | Maximum
     
EQUITY      
Award vesting period from the date of grant 3 years    
Restricted stock
     
EQUITY      
Number of plans under award 2    
Shares      
Outstanding at the beginning of the period (in shares) 11,200    
Granted (in shares) 51,800    
Vested (in shares) (11,200)    
Cancelled, expired or forfeited (in shares) (200)    
Outstanding at the end of the period (in shares) 51,600 11,200  
Weighted Average Grant Date Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 17.73    
Granted (in dollars per share) $ 25.89    
Vested (in dollars per share) $ 17.73    
Cancelled, expired or forfeited (in dollars per share) $ 25.25    
Outstanding at the end of the period (in dollars per share) $ 25.89 $ 17.73  
Additional disclosures      
Total fair value of restricted stock vested 299,000 413,000 340,000
Director Plan | Restricted stock
     
EQUITY      
Common stock value that can be purchased $ 50,000    
Award vesting period from the date of grant 1 year    
Number of shares authorized for grant 200,000    
Number of shares available for future grant 67,200    
Shares      
Granted (in shares) 9,000    
Director Plan | Restricted stock | Minimum
     
EQUITY      
Vesting requirement condition, percentage of attendance in regularly scheduled board meetings 75.00%    
Employee Plan | Restricted stock
     
EQUITY      
Award vesting period from the date of grant 1 year    
Number of shares authorized for grant 200,000    
Number of shares available for future grant 72,062    
Shares      
Granted (in shares) 42,800